202 related articles for article (PubMed ID: 18592007)
1. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
Hoffmann AC; Mori R; Vallbohmer D; Brabender J; Klein E; Drebber U; Baldus SE; Cooc J; Azuma M; Metzger R; Hoelscher AH; Danenberg KD; Prenzel KL; Danenberg PV
Neoplasia; 2008 Jul; 10(7):674-9. PubMed ID: 18592007
[TBL] [Abstract][Full Text] [Related]
2. High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF.
Hoffmann AC; Mori R; Vallbohmer D; Brabender J; Drebber U; Baldus SE; Klein E; Azuma M; Metzger R; Hoffmann C; Hoelscher AH; Danenberg KD; Prenzel KL; Danenberg PV
J Gastrointest Surg; 2008 Oct; 12(10):1674-81; discussion 1681-2. PubMed ID: 18704599
[TBL] [Abstract][Full Text] [Related]
3. A three-gene signature for outcome in soft tissue sarcoma.
Hoffmann AC; Danenberg KD; Taubert H; Danenberg PV; Wuerl P
Clin Cancer Res; 2009 Aug; 15(16):5191-8. PubMed ID: 19671876
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
5. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
6. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
[TBL] [Abstract][Full Text] [Related]
7. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
[TBL] [Abstract][Full Text] [Related]
8. S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Fujita H; Nakata K; Ueda J; Sato N; Nagai E; Tanaka M
J Gastrointest Surg; 2009 Oct; 13(10):1852-8. PubMed ID: 19653048
[TBL] [Abstract][Full Text] [Related]
9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer.
Rahbari NN; Schmidt T; Falk CS; Hinz U; Herber M; Bork U; Büchler MW; Weitz J; Koch M
BMC Cancer; 2011 Jul; 11():286. PubMed ID: 21729304
[TBL] [Abstract][Full Text] [Related]
11. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
[TBL] [Abstract][Full Text] [Related]
12. The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma.
Ikeda N; Nakajima Y; Sho M; Adachi M; Huang CL; Iki K; Kanehiro H; Hisanaga M; Nakano H; Miyake M
Cancer; 2001 Aug; 92(3):488-99. PubMed ID: 11505392
[TBL] [Abstract][Full Text] [Related]
13. PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer.
Ma C; Guo Y; Zhang Y; Duo A; Jia Y; Liu C; Li B
Biochem Biophys Res Commun; 2018 Jun; 501(3):654-660. PubMed ID: 29758199
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
15. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
16. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes.
Mori R; Dorff TB; Xiong S; Tarabolous CJ; Ye W; Groshen S; Danenberg KD; Danenberg PV; Pinski JK
Prostate; 2010 Nov; 70(15):1692-700. PubMed ID: 20564320
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.
Fujioka S; Yoshida K; Yanagisawa S; Kawakami M; Aoki T; Yamazaki Y
Cancer; 2001 Oct; 92(7):1788-97. PubMed ID: 11745251
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
19. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.
Seo Y; Baba H; Fukuda T; Takashima M; Sugimachi K
Cancer; 2000 May; 88(10):2239-45. PubMed ID: 10820344
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]